RAPT vs TECH · $132.1M cap vs P/E 65, rev $1.22B
RAPT Therapeutics Inc (RAPT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RAPT currently screens at market cap $132.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RAPT and TECH stock pages for the full models.
Not investment advice.